Zobrazeno 1 - 10
of 33
pro vyhledávání: '"A. S. Kalpinsky"'
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 4, Pp 16-24 (2022)
Risk factors for renal cell cancer (RCC) recurrence, including its local form, include stage and high Fuhrman grading system score, regional lymph node involvement, microvascular invasion, tumor necrosis, positive surgical margin, and sarcomatoid or
Externí odkaz:
https://doaj.org/article/64a39eadb1a14ef5b7fff91e735d8d3e
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 48-55 (2016)
Information about retraction of an articleAnalysis conducted by the members of the editorial board has revealed the direct borrowing without reference to the specific source of citations in the following articles:The article by Alekseev B.Ya., Nyushk
Externí odkaz:
https://doaj.org/article/a975c860d81347d2b9b83ed7f5cf029b
Autor:
N. V. Karpova, M. V. Ivanov, V. A. Mileiko, A. A. Rumyantsev, T. A. Titova, G. A. Arakelyan, A. P. Oganesyan, A. V. Kanygina, E. I. Sharova, R. A. Gafanov, A. S. Kalpinsky, B. Y. Alekseev, A. I. Semenova, S. A. Protsenko, F. V. Moiseenko, V. B. Matveev, D. A. Nosov
Publikováno v:
Malignant tumours. 11:23-35
Nivolumab was registered in Russia in December 2016 as a monotherapy for advanced renal cell carcinoma (RCC) and it remains a second‑line treatment choice for patients with disease progression after the use of tyrosine kinase inhibitors. Even thoug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0807e07de5583c63ed49d7ef3f303415
https://doi.org/10.18027/2224-5057-2021-11-3-23-35
https://doi.org/10.18027/2224-5057-2021-11-3-23-35
Autor:
Margarita Y Gaas, Andrey D Kaprin, Nikolay V Vorobyev, Leonid M Rapoport, Dmitry O Korolev, Alexey S Kalpinsky
Publikováno v:
Urologia.
The influence of various morphological, anatomical, genetic and other factors on the local recurrence-free survival of patients who have undergone different renal cell cancer (RCC) treatment is still a rather complex, ambiguous and controversial issu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4542d23fae42cb8312aeb095faa4dc47
https://pubmed.ncbi.nlm.nih.gov/36515572
https://pubmed.ncbi.nlm.nih.gov/36515572
Publikováno v:
Onkourologiâ, Vol 2, Iss 3, Pp 19-24 (2020)
Sixty hundred and twenty-six case histories of patients with renal-cell carcinoma, who underwent nephrectomy at the Department of Oncourology, P.A. Herzen Moscow Research Oncological Institute, in November 1992 to November 2005, have been restrospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::ccdadd17630b30e28a1a8f993ca26dbf
https://oncourology.abvpress.ru/oncur/article/view/1163
https://oncourology.abvpress.ru/oncur/article/view/1163
Autor:
I. G. Rusakov, A. S. Kalpinsky
Publikováno v:
Onkourologiâ, Vol 3, Iss 1, Pp 10-16 (2020)
Treatment of complications due to both early and end-stage urological cancers and those resulting from chemo- or radiotherapy is currently a topical problem.Anemia in cancer patients is a complex syndrome that is caused by the disease and may be trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::2d61323d3bb782763b4b1e265e270333
https://oncourology.abvpress.ru/oncur/article/view/1079
https://oncourology.abvpress.ru/oncur/article/view/1079
Autor:
M. I. Volkova, A. M. Abdelgafur, M. T. Aivazov, Z. V. Amoev, K. G. Babina, P. S. Borisov, A. A. Vorontsovа, I. V. Evstigneeva, O. I. Evsyukova, O. V. Zhelezin, A. S. Kalpinsky, E. V. Karabina, N. V. Kirdakova, G. P. Kolesnikov, E. S. Kuzmina, D. Kh. Latipova, R. V. Leonenkov, M. R. Maturov, A. V. Meskikh, S. V. Mishugin, E. G. Ovchinnikova, A. S. Olshanskaya, S. A. Protsenko, T. Yu. Semiglazova, R. V. Smirnov, E. A. Usynin, M. M. Fael, E. M. Cherniakova, I. E. Shumskaya
Publikováno v:
Onkourologiâ, Vol 15, Iss 3, Pp 56-69 (2019)
Objective: an assessment of efficacy and safety of lenvatinib in combination with everolimus in unselected patients with metastatic renal cell carcinoma (mRCC) progressed during or following ≥1 line of antiangiogenic targeted therapy.Material. Russ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d301a22b53e5e52911c9452451cbb9
https://oncourology.abvpress.ru/oncur/article/view/984
https://oncourology.abvpress.ru/oncur/article/view/984
Autor:
A. S. Kalpinsky, V.M. Perepukhov, B. Ya. Alekseev, M.P. Golovashchenko, A. A. Krasheninnikov, N. V. Vorobyev, Kirill M. Nyushko
Publikováno v:
Onkologiya. Zhurnal imeni P.A.Gertsena. 10:62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a32aae0f926e938ed7648a771ddb7b1
https://doi.org/10.17116/onkolog20211002162
https://doi.org/10.17116/onkolog20211002162
Autor:
A. S. Kalpinsky, B. Ya. Alekseev, R.L. Sugaipov, V.M. Perepukhov, O.A. Mailyan, N. V. Vorobyev, M.P. Golovashchenko
Publikováno v:
Onkologiya. Zhurnal imeni P.A.Gertsena. 10:49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b47fc44292976b13081e37132481b855
https://doi.org/10.17116/onkolog20211004149
https://doi.org/10.17116/onkolog20211004149
Autor:
A. A. Krasheninnikov, B. Ya. Alekseev, Kirill M. Nyushko, N. V. Vorobyev, Andrey Kaprin, M.P. Golovashchenko, A. S. Kalpinsky
Publikováno v:
Onkologiya. Zhurnal imeni P.A.Gertsena. 10:12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bae46cc2fedd213d2d457fd4cc5a896
https://doi.org/10.17116/onkolog20211001112
https://doi.org/10.17116/onkolog20211001112